Gastrin-releasing peptide receptor overall percentage and intensity of tumor cell expression staining were more pronounced in clinical stages III and IV and extensive disease compared with GRPR expression in clinical stages I and II.
Gastrin-releasing peptide receptor content in human glioma and normal brain.
Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells.
Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.
Gastrin-releasing peptide receptor expression in non-cancerous bronchial epithelia is associated with lung cancer: a case control study.
Membranous and cytoplasmic immunolocalization of gastrin-releasing peptide receptor in non-small cell lung carcinoma tissue.
Gastrin-releasing peptide receptor (GRPR) expression in males and females showing no detectable difference in GRPR expression.